130 Real-world effectiveness of Durvalumab: 5 year survival outcomes and prognostic analyses

Lung Cancer 2026

View at publisher

Authors: Praveen Baskar, Keerthi Vivekanandan, Saranya Vivekanandan, Anuar Binti Mohammad, Hanee Nur Farah, Raafat Malek

DOI: 10.1016/j.lungcan.2026.109079

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Inflammatory Biomarkers in Disease Prognosis Lung Cancer Research Studies